Iwan Paolucci

Dr. Iwan Paolucci

The University of Texas MD Anderson Cancer Center
orcid

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2023 in Radiology
Verified
Journal Article
Closed access
YLYuan-Mao Lin
Yuan-Mao Lin
IPIwan Paolucci
Iwan Paolucci
COCaleb S. O’connor
Caleb S. O’connor
BABrian Mark Anderson
Brian Mark Anderson
BRBastien Rigaud
Bastien Rigaud
BOBruno C. Odisio
Bruno C. Odisio
Ablative margin quantified using biomechanical deformable CT image registration with artificial intelligence–based autosegmentation was strongly associated and spatially localized within local dise... Background Confirming ablation completeness with sufficient ablative margin is critical for local tumor control following colorectal liver metastasis (CLM) ablation. An image-based confirmation met...

4 August 2021 in Cancers
Verified
Journal Article
Open access
PDF file
YLYuan-Mao Lin
Yuan-Mao Lin
IPIwan Paolucci
Iwan Paolucci
Kristy K BrockKristy K Brock
Kristy K Brock
BOBruno C. Odisio
Bruno C. Odisio
Image-guided ablation can provide effective local tumor control in selected patients with CLM. A randomized controlled trial suggested that radiofrequency ablation combined with systemic chemotherapy resulted in a survival benefit for patients with unresectable CLM, compared to systemic chemotherapy alone. For small tumors, ablation with adequate margins can be considered as an alternative to resection. The improvement of ablation technologies can allow the treatment of tumors close to major vascular structures or bile ducts, on which the applicability of thermal ablation modalities is challenging. Several factors affect the outcomes of ablation, including but not limited to tumor size, number, location, minimal ablation margin, RAS mutation status, prior hepatectomy, and extrahepatic disease. Further understanding of the impact of tumor biology and advanced imaging guidance on overall patient outcomes might help to tailor its application, and improve outcomes of image-guided ablation.

16 October 2019 in Journal of Gastrointestinal Surgery
Verified
Journal Article
Closed access
PDF file
GPGian Andrea Prevost
Gian Andrea Prevost
BEBenjamin Eigl
Benjamin Eigl
IPIwan Paolucci
Iwan Paolucci
TRTobias Rudolph
Tobias Rudolph
MPMatthias Peterhans
Matthias Peterhans
ALAnja Lachenmayer
Anja Lachenmayer

30 August 2024 in British Journal of Surgery
Verified
Journal Article
Closed access
PDF file
IPIwan Paolucci
Iwan Paolucci
JSJessica Albuquerque Marques Silva
Jessica Albuquerque Marques Silva
YLYuan-Mao Lin
Yuan-Mao Lin
GLGregor Laimer
Gregor Laimer
VCValentina Cignini
Valentina Cignini
BOBruno C. Odisio
Bruno C. Odisio
Background: Several ablation confirmation software methods for minimum ablative margin assessment have recently been developed to improve local outcomes for patients undergoing thermal ablation of colorectal liver metastases. Previous assessments were limited to single institutions mostly at the place of development. The aim of this study was to validate the previously identified 5 mm minimum ablative margin (A0) using autosegmentation and biomechanical deformable image registration in a multi-institutional setting. Methods: This was a multicentre, retrospective study including patients with colorectal liver metastases undergoing CT- or ultrasound-guided microwave or radiofrequency ablation during 2009–2022, reporting 3-year local disease progression (residual unablated tumour or local tumour progression) rates by minimum ablative margin across all institutions and identifying an intraprocedural contrast-enhanced CT-based minimum ablative margin associated with a 3-year local disease progression rate of less than 1%. Results: A total of 400 ablated colorectal liver metastases (median diameter of 1.5 cm) in 243 patients (145 men; median age of 62 [interquartile range 54–70] years) were evaluated, with a median follow-up of 26 (interquartile range 17–40) months. A total of 119 (48.9%) patients with 186 (46.5%) colorectal liver metastases were from international institutions B, C, and D that were not involved in the software development. Three-year local disease progression rates for 0 mm, >0 and <5 mm, and 5 mm or larger minimum ablative margins were 79%, 15%, and 0% respectively for institution A (where the software was developed) and 34%, 19%, and 2% respectively for institutions B, C, and D combined. Local disease progression risk decreased to less than 1% with an intraprocedurally confirmed minimum ablative margin greater than 4.6 mm. Conclusion: A minimum ablative margin of 5 mm or larger demonstrates optimal local oncological outcomes. It is proposed that an intraprocedural minimum ablative margin of 5 mm or larger, confirmed using biomechanical deformable image registration, serves as the A0 for colorectal liver metastasis thermal ablation.

10 March 2021 in Frontiers in Oncology
Verified
Journal Article
Open access
RSRaluca-Maria Sandu
Raluca-Maria Sandu
IPIwan Paolucci
Iwan Paolucci
SRSimeon J. S. Ruiter
Simeon J. S. Ruiter
RSRaphael Sznitman
Raphael Sznitman
KJKoert P. de Jong
Koert P. de Jong
PTPascale Tinguely
Pascale Tinguely
Background: In thermal ablation of liver tumors, complete coverage of the tumor volume by the ablation volume with a sufficient ablation margin is the most important factor for treatment success. Evaluation of ablation completeness is commonly performed by visual inspection in 2D and is prone to inter-reader variability. This work aimed to introduce a standardized approach for evaluation of ablation completeness after CT-guided thermal ablation of liver tumors, using volumetric quantitative ablation margins (QAM).Methods: A QAM computation metric based on volumetric segmentations of tumor and ablation areas and signed Euclidean surface distance maps was developed, including a novel algorithm to address QAM computation in subcapsular tumors. The code for QAM computation was verified in artificial examples of tumor and ablation spheres simulating varying scenarios of ablation margins. The applicability of the QAM metric was investigated in representative cases extracted from a prospective database of colorectal liver metastases (CRLM) treated with stereotactic microwave ablation (SMWA).Results: Applicability of the proposed QAM metric was confirmed in artificial and clinical example cases. Numerical and visual options of data presentation displaying substrata of QAM distributions were proposed. For subcapsular tumors, the underestimation of tumor coverage by the ablation volume when applying an unadjusted QAM method was confirmed, supporting the benefits of using the proposed algorithm for QAM computation in these cases. The computational code for developed QAM was made publicly available, encouraging the use of a standard and objective metric in reporting ablation completeness and margins.Conclusion: The proposed volumetric approach for QAM computation including a novel algorithm to address subcapsular liver tumors enables precision and reproducibility in the assessment of ablation margins. The quantitative feedback on ablation completeness opens possibilities for intra-operative decision making and for refined analyses on predictability and consistency of local tumor control after thermal ablation of liver tumors.

31 May 2024 in Cancers
Verified
Journal Article
Open access
PDF file
AHAmirreza Heshmat
Amirreza Heshmat
COCaleb S. O’connor
Caleb S. O’connor
JSJessica Albuquerque Marques Silva
Jessica Albuquerque Marques Silva
IPIwan Paolucci
Iwan Paolucci
AJAaron Kyle Jones
Aaron Kyle Jones
Kristy K BrockKristy K Brock
Kristy K Brock
Microwave ablation (MWA) of liver tumors presents challenges like under- and over-ablation, potentially leading to inadequate tumor destruction and damage to healthy tissue. This study aims to develop personalized three-dimensional (3D) models to simulate MWA for liver tumors, incorporating patient-specific characteristics. The primary objective is to validate the predicted ablation zones compared to clinical outcomes, offering insights into MWA before therapy to facilitate accurate treatment planning. Contrast-enhanced CT images from three patients were used to create 3D models. The simulations used coupled electromagnetic wave propagation and bioheat transfer to estimate the temperature distribution, predicting tumor destruction and ablation margins. The findings indicate that prolonged ablation does not significantly improve tumor destruction once an adequate margin is achieved, although it increases tissue damage. There was a substantial overlap between the clinical ablation zones and the predicted ablation zones. For patient 1, the Dice score was 0.73, indicating high accuracy, with a sensitivity of 0.72 and a specificity of 0.76. For patient 2, the Dice score was 0.86, with a sensitivity of 0.79 and a specificity of 0.96. For patient 3, the Dice score was 0.8, with a sensitivity of 0.85 and a specificity of 0.74. Patient-specific 3D models demonstrate potential in accurately predicting ablation zones and optimizing MWA treatment strategies.